Internal Medicine Journal · 2011 · 26 citations · 14 references
MedicineCardiologyPediatricsClinical CardiologyPediatric CardiologyPulmonologyCardiovascular DiseaseCongenital Heart DiseaseCongenital Structural Heart DiseaseHypertension In ChildrenPulmonary HypertensionPulmonary Vascular DiseaseEisenmenger SyndromePediatric Pulmonary HypertensionPulmonary Arterial PressurePulmonary Artery Pressure MeasurementPulmonary Hypertension Due To Congenital Heart Disease
BACKGROUND/AIMS: Pulmonary arterial hypertension (PAH) frequently accompanies childhood congenital heart disease (CHD) and may persist into adult life. The advent of specific PAH therapies for PAH prompted formation of a national Australian and New Zealand registry in 2010 to document the incidence, demographics, presentation and outcomes for these patients. METHODS: This multicentre, prospective, web-based registry enrols patients with CHD-associated PAH being followed in a tertiary centre. The inclusion criteria stipulated patient age ≥16 years, a measured mean pulmonary arterial pressure >25 mmHg at rest or echocardiographical evidence of PAH or a diagnosis of Eisenmenger syndrome, and followed since 1 January 2000. A single observer collected standardised data during a series of site visits. RESULTS: Of the first 50 patients enrolled, 30 (60%) were female. The mean age (standard deviation (SD)) at the time of PAH diagnosis or confirmation in an adult centre was 27.23 (10.07) years, and 32 (64%) patients are currently aged >30 years. Fourteen (28%) patients were in World Health Organization Functional Class II and 36 (72%) in Class III at the time of diagnosis. Forty-seven of 50 (94%) had congenital systemic-pulmonary shunts, and 36 (72%) never underwent intervention. Thirteen (26%) had Down syndrome. Confirmation of PAH by recent cardiac catheterisation was available in 30 (60%) subjects. During follow up, a total of 32 (64%) patients received a PAH-specific therapy. CONCLUSIONS: CHD associated with PAH in adult life has resulted in a new population with unique needs. This registry will allow documentation of clinical course and long-term outcomes for these patients.
14
Nazzareno Galiè, Marius M. Hoeper, Marc Humbert et al. · European Heart Journal · 2009 · 3.9K citations · Full text
Pulmonary Arterial Hypertension in France
Marc Humbert, Olivier Sitbon, Ari Chaouat et al. · American Journal of Respiratory and Critical Care Medicine · 2006 · 2K citations
Congenital Heart Disease in the General Population
Ariane Marelli, Andrew S. Mackie, Raluca Ionescu‐Ittu et al. · Circulation · 2007 · 1.7K citations · Full text
Medicine, Cardiology, Pediatrics +12
Predicting Survival in Pulmonary Arterial Hypertension
Raymond L. Benza, Dave P. Miller, Mardi Gomberg‐Maitland et al. · Circulation · 2010 · 1.6K citations · Full text
Bosentan Therapy in Patients With Eisenmenger Syndrome
Nazzareno Galiè, Maurice Beghetti, Michael Α. Gatzoulis et al. · Circulation · 2006 · 836 citations · Full text
Medicine, Cardiology, Pharmacology +17